Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses
Clinical trial NCT06338826 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06338826
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-09-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.